Diurnal variation of methotrexate disposition in children with acute leukaemia |
| |
Authors: | G. Ferrazzini H. Sohl I. Robieux D. Johnson E. Giesbrecht G. Koren |
| |
Affiliation: | (1) Division of Clinical Pharmacology, The Hospital of Sick Children, Toronto, Canada;(2) Career Scientist, Ontario Ministry of Health, Canada |
| |
Abstract: | Summary There is recent evidence that survival is improved when maintenance therapy for acute lymphocytic leukaemia in children is given at night. We have examined the possibility that diurnal variation in methotrexate pharmacokinetics may contribute to this improvement.In 6 children with leukaemia there was a significant fall in methotrexate plasma clearance at night (from 5.6 to 4.7 ml·kg–1·min–1). Renal clearance of methotrexate tended to fall at night and unbound renal clearance fell significantly (from 17.5 to 8.5 ml·min–1·kg–1P<0.05). Creatinine clearance did not exhibit diurnal variation, whereas there was a significant fall in the non-glomerular clearance of methotrexate (from 14.8 to 6 ml·min–1·kg–1).Since methotrexate is a weak organic acid, its tubular secretion depends on urinary pH. At night urinary pH is more acidic, and this may result in more reabsorption and hence reduced renal clearance. |
| |
Keywords: | Methotrexate children leukaemia chronopharmacology |
本文献已被 SpringerLink 等数据库收录! |